PHILADELPHIA -- Current anticoagulant or antiplatelet use is not necessarily a contraindication for administering tissue plasminogen activator (tPA) to a stroke patient in the emergency department, a ...
WASHINGTON, Aug. 4-Medicare is about to announce that beginning in October it will start paying hospitals for use of the thrombolytic drug tissue plasminogen activator (tPA) for treatment of ischemic ...
The American Heart Association/American Stroke Association has issued a new scientific statement on the rationale for the inclusion and exclusion criteria for intravenous alteplase (tissue plasminogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results